XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Note 6 - Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2022
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

  

2021

 

Dividend yield

  0%  0%

Expected life (years)

  4.9   4.9 

Expected volatility

  111%  83%

Risk-free interest rate

  1.8%  0.4%
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

  

2021

 

Cost of revenue — Edge to Cloud

 $6  $15 

Selling, general and administrative

  66   146 

Research and development

  3   7 

Total stock-based compensation expense

 $75  $168 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
          

Weighted

     
          

Average

     
          

Remaining

     
      

Weighted

  

Contractual

     
  

Number of

  

Average

  

Life

  

Aggregate

 
  

Shares

  

Exercise Price

  

(in years)

  

Intrinsic Value

 

Balance at December 31, 2021

  1,664,014  $2.07   6.64  $405,223 

Granted

  50,000   1.84         

Exercised

  (54,167)  1.20         

Forfeited

  (8,125)  1.02         

Expired

  (26,625)  3.45         

Balance at March 31, 2022

  1,625,097   2.07   6.70   385,088 

Vested and expected to vest at March 31, 2022

  1,625,097   2.07   6.70   385,088 

Exercisable at March 31, 2022

  988,838  $2.38   6.13  $189,808 
Schedule of Share Based Compensation Additional Stock Options Activity [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

  

2021

 

Weighted average grant-date fair value of options granted during the period

 $1.84  $3.17 

Options in-the-money (in shares)

  312,661   550,733 

Aggregate intrinsic value of options exercised during the period

 $1.20  $5.15 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Number of

  

Weighted Average

 
  

Shares

  

Award Price

 

Unvested at December 31, 2021

  34,614  $2.72 

Granted

      

Vested

  (17,307)  2.72 

Forfeited

      

Unvested at March 31, 2022

  17,307   2.72 

Expected to vest after March 31, 2022

  17,307  $2.72 
Schedule of Common Stock Reserved For Future Issuance [Table Text Block]
  

March 31, 2022

 

Stock options outstanding

  1,625,097 

Restricted stock units and performance stock units outstanding

  433,974 

Stock options and restricted stock units available for future grant

  1,045,772 

Common stock reserved for future issuance

  3,104,843